Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Optogenetics Industry By 2029?

The expansion of the optogenetics market has been swift in the recent past, escalating from $35.91 billion in 2024 to $40.9 billion in 2025, marking a compound annual growth rate (CAGR) of 13.9%. The remarkable growth during the historical timeframe can be credited to a variety of factors including the surge in neurological disorders, an increase in funding for life sciences, advancements in drug discovery and development, progress in mapping neural circuits, the application of optogenetics in drug screening, and breakthroughs in neurophotonics.

The market for optogenetics is anticipated to experience a swift expansion in the upcoming years, reaching $71.21 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 14.9%. This projected growth during the forecasted period is due to factors like its applications in therapy, clinical trials, and translations, its usage in non-neuronal cells, contributions to brain-machine interfaces, and the creation of new light-sensitive proteins. Key trends during this future period include progress in optogenetic tools and technologies, partnerships with pharmaceutical firms, the use of optogenetics in drug discovery and R&D, expansion to non-neuronal cell types, and merging with other imaging technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

Which Industry Forces Are Driving The Optogenetics Market Forward?

The surge in Parkinson’s disease and epilepsy globally is predicted to stimulate the expansion of the optogenetics market. Parkinson’s disease (PD) can be described as a degenerative brain condition, which triggers motor symptoms like slow motion tremors, stiffness, and imbalance. It is also linked with cognitive decline, mental health disorders, difficulty in sleeping, pain, and sensory disturbances. Epilepsy, another brain disorder, culminates in seizures. The treatment of Parkinson’s disease in optogenetic therapy involves using proteins which react to specific light wavelengths. Gene therapy techniques are used to manufacture these proteins, which are programmed to activate or inactivate when subjected to specific light categories, consequently, normalizing brain function in Parkinson’s disease patients. Data from The Parkinson’s Foundation, a US organization committed to enhancing the lives of those affected by Parkinson’s disease, confirmed a substantial increase in annual Parkinson’s disease diagnosis in December 2022 to almost 90,000, a significant leap from the prior figure of 60,000. Furthermore, the number of individuals in the U.S. living with PD is projected to grow to 1.2 million by 2030 from 930,000 in 2020. Thus, the worldwide rise in Parkinson’s disease and epilepsy incidences are fueling the ascent of the optogenetics market.

What Is The Segment Breakdown Of The Optogenetics Market?

The optogeneticsmarket covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

How Are Global Trends Impacting The Development Of The Optogenetics Market?

Pioneering new systems is a significant trend that has risen in prominence in the optogenetics market. Large-scale businesses in the optogenetics field are constructing state-of-the-art optogenetics tools and systems to keep their market position intact. For example, in June 2022, Bruker Corporation, an American-based creator of optogenetics tools, introduced NeuraLight 3D Ultra, an improved 3D holographic stimulation for optogenetics modules, designed to aid complex neuroscience and optogenetics research on Bruker’s Ultima 2Pplus Multiphoton Microscope. This new innovation delivers advanced 3D holographic photostimulation, specifically tailored to aid in-depth functional research on neural networks and brain computation.

Which Companies Are Contributing Significantly To The Optogenetics Market Growth?

Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Which Region Is Leading Innovation In The Optogenetics Market?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9009&type=smp

Browse Through More Reports Similar to the Global Optogenetics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Tumor Embolization Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model